Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart DiseaseDavid W. Brown, Samuel P. Hanke, Robert H. Beekman et al.|Journal of the American Heart Association|2016Cited by 74
Quality improvement through collaborationSarah Clauss, Gerard R. Martin, Jeffrey Anderson et al.|Current Opinion in Pediatrics|2015Cited by 38
Transparency in a Pediatric Quality Improvement Collaborative: A Passionate Journey by NPC-QIC Clinicians and ParentsStacey Lihn, Robert H. Beekman, John D. Kugler et al.|Congenital Heart Disease|2015Cited by 23
Optimizing patient care and outcomes through the congenital heart center of the 21st centuryJeffery B. Anderson, Robert M. Campbell, Devyani Chowdhury et al.|Congenital Heart Disease|2018Cited by 13
DIGOXIN USE AT DISCHARGE IS ASSOCIATED WITH REDUCED INTERSTAGE MORTALITY AFTER STAGE I PALLIATION FOR SINGLE VENTRICLE HEART DISEASEDavid W. Brown, Carole Lannon, Steven R. Neish et al.|Journal of the American College of Cardiology|2015Cited by 4